CAM
ZSPH

Cormorant Asset Management’s ZS PHARMA INC COMS TK (DE) ZSPH Stock Holding History

Cormorant Asset Management’s Portfolio ZSPH Stock Details ZSPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-50,000
Closed -$1.96M – 76
2014
Q3 		$1.96M Buy
+50,000
New +$1.65M 0.4% 51

Other funds holding ZSPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DPA
Devon Park Associates $30.8M AUM 0.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Cormorant Asset Management's ZSPH Position: Q4 2014 in Review

Cormorant Asset Management sold out of ZS PHARMA INC COMS TK (DE) (ZSPH) in Q4 2014, closing a stake of 50,000 shares — an estimated $1.96M sold.

Cormorant Asset Management first reported a position in ZSPH in Q3 2014 and held it in 1 quarter. The position peaked at $1.96M in Q3 2014. 78 funds tracked by Wall St. Rank hold ZSPH as of Q4 2014.

  • Cormorant Asset Management reported no remaining ZS PHARMA INC COMS TK (DE) position as of Q4 2014 after selling out during the quarter.
  • Cormorant Asset Management sold 50,000 ZS PHARMA INC COMS TK (DE) shares in Q4 2014, an estimated $1.96M.
  • Cormorant Asset Management first reported a position in ZS PHARMA INC COMS TK (DE) in Q3 2014 and held it in 1 quarter.
  • Cormorant Asset Management's ZS PHARMA INC COMS TK (DE) position peaked at $1.96M in Q3 2014.
  • 78 funds tracked by Wall St. Rank held ZS PHARMA INC COMS TK (DE) as of Q4 2014.

Based on Cormorant Asset Management's 13F filing for Q4 2014, filed 17 Feb 2015.